4//SEC Filing
Kawakami Mark 4
Accession 0000950170-24-099338
CIK 0001469443other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 8:11 PM ET
Size
5.4 KB
Accession
0000950170-24-099338
Insider Transaction Report
Form 4
Kawakami Mark
Chief Financial Officer
Transactions
- Purchase
Common Stock
2024-08-01$2.06/sh+700$1,442→ 1,981 total
Footnotes (2)
- [F1]Reflects the purchase of 700 shares of the Issuer's common stock on 8/1/24 at a per share purchase price of $2.06 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock.
- [F2]The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase periods from February 1, 2022 to August 1, 2024. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase.
Documents
Issuer
Arcadia Biosciences, Inc.
CIK 0001469443
Entity typeother
Related Parties
1- filerCIK 0002030709
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 8:11 PM ET
- Size
- 5.4 KB